Results 161 to 170 of about 15,165 (218)

The Cardiovascular Effect of Tirzepatide: A Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide Dual Agonist. [PDF]

J Lipid Atheroscler, 2023
Cho YK, La Lee Y, Jung CH.
europepmc   +1 more source

Body Composition Optimization in the Era of GLP‐1‐Based Pharmacotherapy for Obesity Management

Lifestyle Medicine, Volume 7, Issue 3, July 2026.
Grant M. Tinsley, Spencer Nadolsky, Karl Nadolsky   +2 more
wiley   +1 more source

Prefecture‐Level Prehospital Glucose Administration for Hypoglycemia and Diabetologist Density Among Older Adults in Japan: A Nationwide Ecological Study

Geriatrics &Gerontology International, Volume 26, Issue 7, July 2026.
Among older adults in Japan, higher diabetologist density was associated with lower rates of hypoglycemic events recognized by Emergency Medical Services (EMS) requiring prehospital glucose administration, despite higher insulin prescribing. These findings support improved access to certified diabetologists and stronger diabetologist–primary care ...
Tomoya Saika, Yuki Kado, Michiko Yamazaki, Tohru Takebe, Masaya Sakamoto, Atsushi Nakagomi   +5 more
wiley   +1 more source

Association of Glucose‐Dependent Insulinotropic Polypeptide Levels With Cardiovascular Mortality in Patients With Acute Myocardial Infarction

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Florian Kahles, Marcia V. Rückbeil, Maria C. Arrivas, Robert W. Mertens, Julia Moellmann, Moritz Biener, Evangelos Giannitsis, Hugo A. Katus, Nikolaus Marx, Michael Lehrke   +9 more
doaj   +1 more source

Glucose-dependent insulinotropic polypeptide regulates body weight and food intake via GABAergic neurons in mice. [PDF]

Nat Metab, 2023
Liskiewicz A, Khalil A, Liskiewicz D, Novikoff A, Grandl G, Maity-Kumar G, Gutgesell RM, Bakhti M, Bastidas-Ponce A, Czarnecki O, Makris K, Lickert H, Feuchtinger A, Tost M, Coupland C, Ständer L, Akindehin S, Prakash S, Abrar F, Castelino RL, He Y, Knerr PJ, Yang B, Hogendorf WFJ, Zhang S, Hofmann SM, Finan B, DiMarchi RD, Tschöp MH, Douros JD, Müller TD.   +30 more
europepmc   +1 more source

Emerging Role of Dual Glucagon-Like Peptide-1 (GLP-1)/Glucose-Dependent Insulinotropic Polypeptide (GIP) Receptor Agonists in Cardiovascular Prevention. [PDF]

Cureus
Contreras Figueroa N, Lopez Mendoza MJ, Ulloa A, Jiron Vindas J, Salazar Estrada MA, Valle Mena MJ.   +5 more
europepmc   +1 more source

The Methylation Analysis of the Glucose-Dependent Insulinotropic Polypeptide Receptor (GIPR) Locus in GH-Secreting Pituitary Adenomas. [PDF]

Int J Mol Sci, 2023
Dalle Nogare M, D'Annunzio S, Vazza G, Regazzo D, Picello L, Denaro L, Voltan G, Scaroni C, Ceccato F, Occhi G.   +9 more
europepmc   +1 more source

Sugar type and route of delivery influence insulin and glucose-dependent insulinotropic polypeptide responses in rats. [PDF]

Am J Physiol Endocrinol Metab
Nisi AV, Arnold MML, Blonde GD, Schier LA, Sanchez-Watts G, Watts AG, Langhans W, Spector AC.   +7 more
europepmc   +1 more source

Positive inotropic effects of glucose-dependent insulinotropic polypeptide in the human atrium and the mouse atrium. [PDF]

Naunyn Schmiedebergs Arch Pharmacol
Neumann J, Hofmann B, Gergs U.
europepmc   +1 more source

Discovery of AMG 133, a Glucose-Dependent Insulinotropic Polypeptide Receptor Antagonist and Glucagon-Like Peptide 1 Receptor Agonist Antibody-Drug Conjugate for the Treatment of Obesity. [PDF]

J Med Chem
Wu B, Falsey JR, Netirojjanakul C, Herberich B, Holder JR, Sham K, Aral J, Forsythe N, Walker KW, Lu SC, Hager T, Stanislaus S, Komorowski R, Atangan L, Achmatowicz M, Romanini D, Weeraratne D, Miranda LP, Véniant MM, Cheng Y.   +19 more
europepmc   +1 more source